Carregant...
Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?
BACKGROUND: Objective means of estimating survival can be used to guide surgical decision-making and to risk-stratify patients for clinical trials. Although a free, online tool (www.pathfx.org) can estimate 3- and 12-month survival, recent work, including a survey of the Musculoskeletal Tumor Societ...
Guardat en:
| Publicat a: | Clin Orthop Relat Res |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5339146/ https://ncbi.nlm.nih.gov/pubmed/27909972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11999-016-5187-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|